Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.63 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | IDO1 | P14902 | 3/20 | 0.54 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | CRHBP | P24387 | 1/20 | 0.53 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | GFER | P55789 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10614200 | 0.90 | TDP1 (0.56) | CYP1A2CYP2C19CYP2C9CYP2D6ALDH1A1 | |
| SCHEMBL29738633 | 0.89 | CYP1A2 (0.53) | CYP1A2CYP2C19CYP2C9CYP2D6ALDH1A1 | |
| SCHEMBL11232421 | 0.87 | CYP1A2 (0.52) | CYP1A2CYP2C19CYP2C9CYP2D6ALDH1A1 | |
| SCHEMBL4639740 | 0.86 | CYP1A2 (0.52) | CYP1A2CYP2C19CYP2C9CYP2D6ALDH1A1 | |
| SCHEMBL10062558 | 0.85 | CYP1A2 (0.50) | CYP1A2CYP2C19CYP2C9CYP2D6ALDH1A1 | |
| SCHEMBL5976506 | 0.85 | CYP1A2 (0.50) | CYP1A2CYP2C19CYP2C9CYP2D6ALDH1A1 | |
| SCHEMBL1082679 | 0.82 | IDO1 (0.54) | CYP1A2CYP2C19CYP2C9CYP2D6ALDH1A1 | |
| SCHEMBL9214204 | 0.81 | CYP2D6 (0.55) | CYP1A2CYP2C19CYP2C9CYP2D6ALDH1A1 | |
| SCHEMBL1148887 | 0.81 | CYP1A2 (0.50) | CYP1A2CYP2C19CYP2C9CYP2D6ALDH1A1 | |
| SCHEMBL5977052 | 0.81 | CYP1A2 (0.47) | CYP1A2CYP2C19CYP2C9CYP2D6ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104230804-B | The preparation method of chemiluminescent substance APS-5 key intermediate | YUNNAN UNIVERSITY OF NATIONALITIES (CN) | 2016-05-25 | — | — | CN | claimed |
| EP-0068294-B1 | A NEW ACARICIDAL COMPOSITION, PROCESSES FOR ITS PRODUCTION AND ITS USE | A. Nattermann & Cie. GmbH (DE) | 1985-12-18 | — | — | EP | claimed |
| JP-8291133-A | — | — | None | — | — | JP | disclosed |
| US-20250177359-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF CANCER AND INFLAMMATORY CONDITIONS | OULUN YLIOPISTO (FI) | 2025-06-05 | — | — | US | disclosed |
| EP-4469046-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF CANCER AND INFLAMMATORY CONDITIONS | Oulun Yliopisto (FI) | 2024-12-04 | — | — | EP | disclosed |
| CN-114213294-B | Method for synthesizing disulfide compound by using basic zeolite molecular sieve as catalyst | 常州大学 | 2024-08-23 | — | — | CN | disclosed |
| US-11970694-B2 | Rapid display method in translational synthesis of peptide | PEPTIDREAM INC. (JP) | 2024-04-30 | — | — | US | disclosed |
| CN-115010632-B | Green synthesis method of mercaptan compounds | 浙江大学衢州研究院 | 2023-09-01 | — | — | CN | disclosed |
| WO-2023144450-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF CANCER AND INFLAMMATORY CONDITIONS | OULUN YLIOPISTO (FI) | 2023-08-03 | — | — | WO | disclosed |
| CN-112321469-B | Synthetic method of dibenzyl sulfide | 成都理工大学 | 2022-07-12 | — | — | CN | disclosed |
| CN-111559976-B | Synthetic method of heteroaryl thioether | 扬州大学 | 2022-05-13 | — | — | CN | disclosed |
| US-4487966-A | 3-Aminomethyl-1-(3-aminopropyl-1-methyl)-4-methylcyclohexane, a process for its preparation and its use | BAYER AKTIENGESELLSCHAFT (DE) | 1984-12-11 | — | — | US | disclosed |
| EP-0074561-B1 | CYCLIC CETO-BUTYRALDEHYDES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THE PREPARATION OF CYCLIC DIISOCYANATES | BAYER AG (DE) | 1984-11-21 | — | — | EP | disclosed |
| EP-0100479-A1 | 3-(Aminomethyl)-1-(3-aminopropyl-1-methyl)-4-methyl cyclohexane, process for its preparation and its use | BAYER AG (DE) | 1984-02-15 | — | — | EP | disclosed |
| EP-0074561-A2 | Cyclic ceto-butyraldehydes, process for their preparation and their use in the preparation of cyclic diisocyanates | BAYER AG (DE) | 1983-03-23 | — | — | EP | disclosed |
| EP-0008763-B1 | AMINOMETHYL-CYCLODODECANES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTICORROSIVES | BAYER AG (DE) | 1981-04-01 | — | — | EP | disclosed |
| US-4251462-A | REACTING 1,5,9-CYCLODODECATRIENE WITH CARBON MONOXIDE AND HYDROGEN, REMOVING CATALYST, REACTING WITH HYDROGEN AND AMMONIA | BAYER AKTIENGESELLSCHAFT (DE) | 1981-02-17 | — | — | US | disclosed |
| EP-0008763-A1 | Aminomethyl-cyclododecanes, a process for their preparation and their use as anticorrosives | BAYER AG (DE) | 1980-03-19 | — | — | EP | disclosed |
| US-4064139-A | TRANQUILIZERS, ANTICONVULSANTS, MUSCLE RELAXANTS, ANTI-PARKINSON'S DISEASE | MERCK & CO., INC. (US) | 1977-12-20 | — | — | US | disclosed |
| US-3954729-A | FROM A SECONDARY AMINE, CARBONYL SULFIDE, AND AN ALKYL HALIDE | IHARA CHEMICAL INDUSTRY CO., LTD. (JA) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250177359-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF CANCER AND INFLAMMATORY CONDITIONS | NAMPT, NADK, NQO1 | CYP1A2 1297/4885CYP2C19 1061/4885CYP2C9 1569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.